Jean-pierre Raynaud
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Final Results of the ANDROCAN Study: Histopathological Characteristics and Biochemical Recurrence at 5 Years of Localized Prostate Cancer According to Preoperative Gonadal Status.
Journal: European urology oncology
Published: May 13, 2024
Intraprostatic hormone dosage: Validation of a novel prostate biopsy technique.
Journal: The French journal of urology
Published: January 04, 2024
Relationship of preoperative androgen levels and metabolic syndrome with quality of life and erectile function in patients who are to undergo radical prostatectomy.
Journal: Asian journal of andrology
Published: March 25, 2021
Metabolic syndrome, levels of androgens, and changes of erectile dysfunction and quality of life impairment 1 year after radical prostatectomy.
Journal: Asian journal of andrology
Published: February 10, 2021
PSA and obesity among men with localized prostate cancer: results of the ANDROCAN study.
Journal: World journal of urology
Published: September 25, 2020
Sex steroids in serum and prostatic tissue of human cancerous prostate (STERKPROSER trial).
Journal: The Prostate
Published: July 09, 2018
Aggressiveness of Localized Prostate Cancer: the Key Value of Testosterone Deficiency Evaluated by Both Total and Bioavailable Testosterone: AndroCan Study Results.
Journal: Hormones & cancer
Published: July 04, 2018
Sexual steroids in serum and prostatic tissue of human non-cancerous prostate (STERPROSER trial).
Journal: The Prostate
Published: June 01, 2017
Obesity and hypogonadism are associated with an increased risk of predominant Gleason 4 pattern on radical prostatectomy specimen.
Journal: Hormone molecular biology and clinical investigation
Published: January 11, 2015
Hormones in normal and pathological prostate.
Journal: Hormone molecular biology and clinical investigation
Published: October 01, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026